JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Technical Notes
TRKC, NTRK3 validated with HTRF KinEASE
TSSK1, STK22D validated with HTRF KinEASE
TSSK2, STK22B validated with HTRF KinEASE
TYK2 validated with HTRF KinEASE
TYRO3 validated with HTRF KinEASE
YES1 validated with HTRF KinEASE
ZAP70 validated with HTRF KinEASE
Epigeneous bromodomain assay: ATAD2A
Epigeneous bromodomain assay: FALZ (BPTF)
Epigeneous bromodomain assay: SMARCA4 (BRG1)
HTRF MLL1/WARD Histone H3K4 di-methylation assay me0-->me2
HTRF MLL1/WARD Histone H3K4 tri-methylation assay me0-->me3
HTRF SET7/9 Histone H3K4 mono-methylation assay me0-->me1
EPIgeneous Cell Based Assay Lysis Buffer Guide
HTRF IP-One assay: a robust and stable platform for high throughput screeni...
Best practices for pharmacological characterization of PPI inhibitors
HTRF 96-well low volume white plate
Protocol for Th17 differentiation from naive CD4+ mouse T-lymphocytes
Protocol for Th17 differentiation from CD4 mouse T-lymphocyte
Key success tips to perform β-arrestin 2 recruitment assays by using the B...
Guidelines for Cell Culture and Lysis in Different Formats Prior to HTRF De...
Optimization and Pharmacological Validation of Wild Type Beta-arrestin 2 Pl...
